Physician profile
Alexander P Anthopoulos
NPI 1700826047
$547.87
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $97.28 · 2021: $68.82 · 2022: $154 · 2023: $10.49 · 2024: $27.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.09 | 2019-2022 | |
| Allergan, INC. | $55.30 | 2019-2020 | |
| Duchesnay USA Incorporated | $40.28 | 2020-2022 | |
| Therapeuticsmd, INC. | $31.07 | 2020-2021 | |
| Smith+Nephew, INC. | $30.93 | 2019 | |
| Boston Scientific Corporation | $27.05 | 2024 | |
| Coopersurgical, INC. | $23.08 | 2019 | |
| Exeltis, USA INC. | $19.03 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.80 | 2021 | |
| Pfizer INC. | $18.14 | 2022 | |
| Astellas Pharma US INC | $17.68 | 2019 | |
| Daiichi Sankyo INC. | $16.65 | 2019 | |
| Myovant Sciences INC. | $15.91 | 2021 | |
| Meditrina | $15.49 | 2022 | |
| Merck Sharp & Dohme LLC | $15.19 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $12.35 | 2019 | |
| Mission Pharmacal Company | $11.34 | 2019 | |
| Mayne Pharma Commercial LLC | $10.49 | 2023 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Anthopoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.